Countries eligible for COF funding should already have made the decision to introduce the targeted product or intervention. Please note that pilot or research projects designed to help the government make the decision to introduce or scale are not eligible. 

All activities must specifically support the government with planning or preparation for government-led introduction. Illustrative examples of eligible activities include: 

• PPH roadmap or scale-up strategy development or costed introduction plan  

• Updates to national guidelines and clinical protocols to adopt new products for PPH prevention, diagnosis and/or treatment 

• Development of national health care worker training curricula/plans  

• Updates to standard essential medicines/equipment lists to include new PPH products  

Note: Non-profit/NGO entities are not eligible to support activities to support local regulatory authority approval. Social marketing organizations (SMOs) and commercial entities proposing to support local regulatory authority approval and country registration will be assessed on a case-by-case basis.  

Introduction preparation activities are underway (e.g., new products included in HMIS, LMIS, training curricula updated, national plan is in place, etc.).  

Strong government endorsement, indicated by a PPH introduction and scale-up plan. Introduction strategies may be stand-alone PPH plans or embedded in other relevant strategies, such as broader maternal health and reproductive health plans. Note: national clinical guidelines or standards of care as evidence do not fulfill this requiement.  

Local regulatory approval or written commitment to pursue an importation waiver by the project start date for the PPH products that your project is working on.   

National guidelines and clinical protocols on PPH management and Essential Medicines List must include relevant PPH products that your project is working on.  

Demonstrate there is sufficient stock of PPH medicines and devices in the country for relevant geographies or confirmed to be arriving in the country to support the needs of the proposed project.  

Rationalized sequencing of activities that aligns supply availability and training.  

Facility and healthcare worker cadre targets for introduction and training activities must be informed by national standards of care and aligned with recommended/appropriate service provision.   

Proposed trainings should leverage cost-efficient, evidence-based models for delivery.   

Routine activities (like EmONC training) may be eligible if applicants demonstrate they are critical to accelerating introduction and scale-up of eligible PPH products AND will be done in a catalytic way.   

Catalytic procurement of models for training and/or activated facilities are eligible in instances of confirmed funding need, exhaustion of other options (e.g. rentals have been explored/exhausted), to catalyze procurement, and a plan for sustainability and replenishment is provided. Proportion of the budget for these equipment must be reasonable.  

Illustrative examples of eligible activities include: 

• Conduct training of trainers on evidenced-based clinical interventions (E-MOTIVE) and new products such as HSC, TXA and drapes  

• Strengthening national coordination and partner coordination of PPH scale-up      

• Kick-starting new PPH supply planning, forecasting and quantification or updating to include new products (e.g., drapes, HSC)  

• Comparative cost analysis of single-use vs. reusable drapes to facilitate scale-up of a more cost-efficient drape option  

• Community-based distribution of misoprostol for PPH prevention